Schneeweiss S - Search Results

1

[Provider profiling: needs, methodologic requirements and means to increase acceptance].

Schneeweiss S, Sangha O. Schneeweiss S, et al. Dtsch Med Wochenschr. 2001 Aug 17;126(33):918-24. doi: 10.1055/s-2001-16503. Dtsch Med Wochenschr. 2001. PMID: 11514928 Review. German. No abstract available.

2

On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective.

Schneeweiss S, Maclure M, Walker AM, Grootendorst P, Soumerai SB. Schneeweiss S, et al. Health Policy. 2001 Feb;55(2):97-109. doi: 10.1016/s0168-8510(00)00120-2. Health Policy. 2001. PMID: 11163649

3

[Patient-centered evaluation of the health status in a longitudinal quality management system in the hospital].

Schneeweiss S, Sangha O, Manstetten A; QMK Entwicklungsgruppe. Schneeweiss S, et al. Gesundheitswesen. 2001 Apr;63(4):205-11. doi: 10.1055/s-2001-12908. Gesundheitswesen. 2001. PMID: 11367949 German.

4

First results from an intensified monitoring system to estimate drug related hospital admissions.

Schneeweiss S, Göttler M, Hasford J, Swoboda W, Hippius M, Hoffmann AK, Riethling AK, Krappweis J. Schneeweiss S, et al. Br J Clin Pharmacol. 2001 Aug;52(2):196-200. doi: 10.1046/j.0306-5251.2001.01425.x. Br J Clin Pharmacol. 2001. PMID: 11488778 Free PMC article.

5

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Schneeweiss S, et al. Am J Epidemiol. 2001 Nov 1;154(9):854-64. doi: 10.1093/aje/154.9.854. Am J Epidemiol. 2001. PMID: 11682368

6

Quasi-experimental longitudinal designs to evaluate drug benefit policy changes with low policy compliance.

Schneeweiss S, Maclure M, Soumerai SB, Walker AM, Glynn RJ. Schneeweiss S, et al. J Clin Epidemiol. 2002 Aug;55(8):833-41. doi: 10.1016/s0895-4356(02)00437-7. J Clin Epidemiol. 2002. PMID: 12384199

7

Costs of measuring outcomes of acute hospital care in a longitudinal outcomes measurement system.

Schneeweiss S, Manstetten A, Wildner M, Sangha O, Liebetrau M, Paeger A. Schneeweiss S, et al. Am J Med Qual. 2003 Jan-Feb;18(1):3-9. doi: 10.1177/106286060301800102. Am J Med Qual. 2003. PMID: 12583639 Free article.

8

A review of uses of health care utilization databases for epidemiologic research on therapeutics.

Schneeweiss S, Avorn J. Schneeweiss S, et al. J Clin Epidemiol. 2005 Apr;58(4):323-37. doi: 10.1016/j.jclinepi.2004.10.012. J Clin Epidemiol. 2005. PMID: 15862718 Review.

9

Understanding secondary databases: a commentary on "Sources of bias for health state characteristics in secondary databases".

Schneeweiss S. Schneeweiss S. J Clin Epidemiol. 2007 Jul;60(7):648-50. doi: 10.1016/j.jclinepi.2006.10.019. Epub 2007 Feb 26. J Clin Epidemiol. 2007. PMID: 17573976 Free PMC article. No abstract available.

10

A basic study design for expedited safety signal evaluation based on electronic healthcare data.

Schneeweiss S. Schneeweiss S. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):858-68. doi: 10.1002/pds.1926. Pharmacoepidemiol Drug Saf. 2010. PMID: 20681003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results